Literature DB >> 28283108

Higher prevalence of restless legs syndrome/Willis-Ekbom disease in multiple sclerosis patients is related to spinal cord lesions.

M Minár1, D Petrleničová2, P Valkovič3.   

Abstract

BACKGROUND: Multiple sclerosis (MS) is connected with higher prevalence of secondary restless legs syndrome/Willis-Ekbom disease (RLS/WED). Aim of this study was to determine risk factor for developing symptoms of RLS in MS patients.
METHODS: In cross-sectional study we examined 200 random MS patients. After obtaining informed consents, patients undervent a structured interview based on RLS and MS symptoms and characteristics, demographic, and health-related data. Than we collected results of brain/spinal cord magnetic resonance imaging (MRI). Blood samples were examined for blood count and biochemistry.
RESULTS: From all 200 subjects, 26% were RLS-positives (95% CI: 20-32%). From positive patients, 44% had negative family history for RLS, and developed secondary RLS after onset of MS. Compared to RLS-negatives, the positives had significantly higher prevalence of spinal cord lesions (p=0.01). Presence of spinal pathology was connected with higher risk of RLS development (OR=3.846, 95%CI:1.304-11.346). There were no statistically significant differences in the levels of red blood cells, iron metabolism parameters, or levels of B or D vitamins.
CONCLUSION: Risk of RLS/WED in MS increases with presence of lesions in spinal cord. The role of decreased dopamine delivery to lower spinal regions as the pathological background must be proved by more detailed research.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Iron metabolism; Restless legs syndrome/Willis-Ekbom disease; Risk factors; Spinal cord lesions; Thyroid gland; Vitamins

Mesh:

Substances:

Year:  2016        PMID: 28283108     DOI: 10.1016/j.msard.2016.12.013

Source DB:  PubMed          Journal:  Mult Scler Relat Disord        ISSN: 2211-0348            Impact factor:   4.339


  7 in total

1.  [Frequent neurological diseases associated with the restless legs syndrome].

Authors:  M Bartl; J Winkelmann; B Högl; W Paulus; C Trenkwalder
Journal:  Nervenarzt       Date:  2018-10       Impact factor: 1.214

2.  Restless legs syndrome, sleep quality, and perceived cognitive impairment in adults with multiple sclerosis.

Authors:  Katie L J Cederberg; Brenda Jeng; Jeffer E Sasaki; Robert W Motl
Journal:  Mult Scler Relat Disord       Date:  2020-05-18       Impact factor: 4.339

Review 3.  The prevalence of restless legs syndrome (RLS) in patients with multiple sclerosis (MS): a systematic review and meta-analysis-an update.

Authors:  Alireza Zali; Mahsa Motavaf; Saeid Safari; Narges Ebrahimi; Mahsa Ghajarzadeh; Reza Jalili Khoshnood; Omid Mirmosayyeb
Journal:  Neurol Sci       Date:  2022-09-05       Impact factor: 3.830

Review 4.  Sleep Abnormalities in Multiple Sclerosis.

Authors:  Giorgos K Sakkas; Christoforos D Giannaki; Christina Karatzaferi; Mauro Manconi
Journal:  Curr Treat Options Neurol       Date:  2019-01-31       Impact factor: 3.598

5.  Impact, Frequency, and Severity of Restless Legs Syndrome in Patients with Multiple Sclerosis in Argentina.

Authors:  Edgar Carnero Contentti; Pablo A López; Debora Nadur; María Eugenia Balbuena; Ana Mariel Finkelstein; Verónica Tkachuk
Journal:  Int J MS Care       Date:  2019 Jul-Aug

6.  Voxel-wise lesion mapping of restless legs syndrome in multiple sclerosis.

Authors:  Kilian Fröhlich; Michael Knott; Stefan Hock; Arnd Dörfler; Frank Seifert; Klemens Winder
Journal:  Neurol Sci       Date:  2022-05-05       Impact factor: 3.830

Review 7.  A global view of comorbidity in multiple sclerosis: a systematic review with a focus on regional differences, methodology, and clinical implications.

Authors:  Larissa Hauer; Julian Perneczky; Johann Sellner
Journal:  J Neurol       Date:  2020-07-27       Impact factor: 4.849

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.